Rapid intestinal ischaemia-reperfusion injury is suppressed in genetically mast cell-deficient Ws/Ws rats - PubMed (original) (raw)
Rapid intestinal ischaemia-reperfusion injury is suppressed in genetically mast cell-deficient Ws/Ws rats
A Andoh et al. Clin Exp Immunol. 1999 Apr.
Abstract
Ws/Ws rats have a small deletion of the c-kit gene, and are deficient in both mucosal and connective tissue-type mast cells. In this study, the role of mucosal type mast cells (MMC) in the development of intestinal ischaemia-reperfusion injury was investigated in Ws/Ws rats. Autoperfused segments of the jejunum were exposed to 60 min of ischaemia, followed by reperfusion for various time periods. The epithelial permeability was then assessed by the 51Cr-EDTA clearance rate. In the control (+/+) rats, the maximal increase in mucosal permeability was achieved at 45 min of reperfusion. In contrast, this increase was significantly and potently attenuated in the Ws/Ws rats. Mucosal alkaline phosphatase activity decreased in the control (+/+) rats, but was not altered in the Ws/Ws rats. There were no differences in mucosal myeloperoxidase activity, indicating that granulocytes did not contribute to tissue injury. These results provide direct evidence for the role of mast cells in the pathogenesis of intestinal ischaemia-reperfusion injury.
Figures
Fig 1
Changes in epithelial permeability induced by ischaemia-reperfusion (I/R) treatment in control (+/+) rats (▪) and Ws/Ws rats (□). Data are expressed as mean ± s.d. (n = 5 per group). *P < 0.01 versus value of respective control (+/+) rats.
Fig 2
Light micrographs of H–E-stained section of rat intestinal mucosa after ischaemia-reperfusion (I/R) treatment. (A) Sham operation. (B) Control (+/+) rats. (C) Ws/Ws rats. (Mag. × 100.)
Fig 3
Changes in the number of mucosal mast cells (a), mucosal alkaline phosphatase (ALP) activity (b), and myeloperoxidase (MPO) activity (c). Data are expressed as mean ± s.d. (n = 5 per group). *P < 0.01; **P < 0.05. NS, Not significant; SO, sham operation.
Similar articles
- Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats.
Araki Y, Andoh A, Fujiyama Y, Bamba T. Araki Y, et al. Clin Exp Immunol. 2000 Feb;119(2):264-9. doi: 10.1046/j.1365-2249.2000.01094.x. Clin Exp Immunol. 2000. PMID: 10632661 Free PMC article. - The role of mast cells in ischemia and reperfusion injury.
Yang MQ, Ma YY, Ding J, Li JY. Yang MQ, et al. Inflamm Res. 2014 Nov;63(11):899-905. doi: 10.1007/s00011-014-0763-z. Epub 2014 Aug 10. Inflamm Res. 2014. PMID: 25108401 Review. - Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats.
Andoh A, Fujiyama Y, Araki Y, Kimura T, Tsujikawa T, Bamba T. Andoh A, et al. Digestion. 2001;63 Suppl 1:103-7. doi: 10.1159/000051920. Digestion. 2001. PMID: 11173919 - A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats.
Kimura T, Andoh A, Fujiyama Y, Saotome T, Bamba T. Kimura T, et al. Clin Exp Immunol. 1998 Mar;111(3):484-90. doi: 10.1046/j.1365-2249.1998.00518.x. Clin Exp Immunol. 1998. PMID: 9528887 Free PMC article. - Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats.
Arizono N, Kasugai T, Yamada M, Okada M, Morimoto M, Tei H, Newlands GF, Miller HR, Kitamura Y. Arizono N, et al. Blood. 1993 May 15;81(10):2572-8. Blood. 1993. PMID: 7683922
Cited by
- Perioperative organ injury.
Bartels K, Karhausen J, Clambey ET, Grenz A, Eltzschig HK. Bartels K, et al. Anesthesiology. 2013 Dec;119(6):1474-89. doi: 10.1097/ALN.0000000000000022. Anesthesiology. 2013. PMID: 24126264 Free PMC article. Review. - Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats.
Araki Y, Andoh A, Fujiyama Y, Bamba T. Araki Y, et al. Clin Exp Immunol. 2000 Feb;119(2):264-9. doi: 10.1046/j.1365-2249.2000.01094.x. Clin Exp Immunol. 2000. PMID: 10632661 Free PMC article. - Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia.
Jiang W, Kirkup AJ, Grundy D. Jiang W, et al. J Physiol. 2011 Aug 1;589(Pt 15):3867-82. doi: 10.1113/jphysiol.2011.209478. Epub 2011 Jun 13. J Physiol. 2011. PMID: 21669977 Free PMC article. - Intestinal mast cells mediate gut injury and systemic inflammation in a rat model of deep hypothermic circulatory arrest.
Karhausen J, Qing M, Gibson A, Moeser AJ, Griefingholt H, Hale LP, Abraham SN, Mackensen GB. Karhausen J, et al. Crit Care Med. 2013 Sep;41(9):e200-10. doi: 10.1097/CCM.0b013e31827cac7a. Crit Care Med. 2013. PMID: 23478660 Free PMC article. - The role of mast cells in ischemia and reperfusion injury.
Yang MQ, Ma YY, Ding J, Li JY. Yang MQ, et al. Inflamm Res. 2014 Nov;63(11):899-905. doi: 10.1007/s00011-014-0763-z. Epub 2014 Aug 10. Inflamm Res. 2014. PMID: 25108401 Review.
References
- Boros M, Kaszaki J, Nagy S. Histamine release during intestinal ischemia-reperfusion: role of irons and hydrogen peroxide. Circ Shock. 1991;35:174–80. - PubMed
- Boros M, Kaszaki J, Nagy S. Oxygen free radical induced histamine release during intestinal ischemia and reperfusion. Eur Surg Res. 1989;21:297–304. - PubMed
- Kubes P, Ibbotson G, Russell JM, et al. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol. 1990;259:G300–g5. - PubMed
- Crowe SE, Perdue MH. Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology. 1992;103:1075–95. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials